Tekla Capital Management LLC Kodiak Sciences Inc. Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$7.09 - $89.45 $60,477 - $763,008
-8,530 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$80.85 - $128.49 $689,650 - $1.1 Million
8,530 New
8,530 $723,000
Q3 2020

Nov 13, 2020
SELL
$45.05 - $59.27 $1.04 Million - $1.37 Million
-23,153 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$38.18 - $73.95 $883,981 - $1.71 Million
23,153 New
23,153 $1.1 Million

Others Institutions Holding KOD

# of Institutions
97
Shares Held
39M
Call Options Held
6.5K
Put Options Held
5.8K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $288M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email